美银全球研究（BofA Global Research）宣布，对生物技术公司Avalo Therapeutics Inc启动研究覆盖，并给予其股票“买入”评级。该机构同时设定了35美元的目标股价，预示着对公司未来前景的积极展望。
美银全球研究（BofA Global Research）宣布，对生物技术公司Avalo Therapeutics Inc启动研究覆盖，并给予其股票“买入”评级。该机构同时设定了35美元的目标股价，预示着对公司未来前景的积极展望。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.